

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.00497257 |
| 2 | protein neddylation (GO:0045116) | 6.59280996 |
| 3 | leukocyte migration involved in inflammatory response (GO:0002523) | 6.03601381 |
| 4 | regulation of platelet aggregation (GO:0090330) | 5.62498496 |
| 5 | regulation of platelet activation (GO:0010543) | 5.43533488 |
| 6 | intra-S DNA damage checkpoint (GO:0031573) | 5.28701354 |
| 7 | angiogenesis involved in wound healing (GO:0060055) | 5.24621653 |
| 8 | regulation of DNA endoreduplication (GO:0032875) | 5.18354026 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.08381376 |
| 10 | protein carboxylation (GO:0018214) | 5.08381376 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.96908305 |
| 12 | positive regulation of respiratory burst (GO:0060267) | 4.95205937 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 4.92692897 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.92692897 |
| 15 | positive regulation of mast cell activation (GO:0033005) | 4.72612163 |
| 16 | neutrophil activation (GO:0042119) | 4.68508076 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 4.66345272 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.66345272 |
| 19 | platelet aggregation (GO:0070527) | 4.65296147 |
| 20 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.57372817 |
| 21 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.57311615 |
| 22 | adenosine receptor signaling pathway (GO:0001973) | 4.55975468 |
| 23 | regulation of metalloenzyme activity (GO:0048552) | 4.47860877 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 4.45762675 |
| 25 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.41519513 |
| 26 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.41519513 |
| 27 | synapsis (GO:0007129) | 4.40085752 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.32821099 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.26715804 |
| 30 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.21469326 |
| 31 | negative regulation of platelet activation (GO:0010544) | 4.16385281 |
| 32 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.14751995 |
| 33 | granulocyte activation (GO:0036230) | 4.14012685 |
| 34 | regulation of fibrinolysis (GO:0051917) | 4.12364502 |
| 35 | bile acid biosynthetic process (GO:0006699) | 4.11966229 |
| 36 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.11774085 |
| 37 | negative regulation of norepinephrine secretion (GO:0010700) | 4.06212474 |
| 38 | reactive oxygen species biosynthetic process (GO:1903409) | 4.05387761 |
| 39 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.05347218 |
| 40 | urea metabolic process (GO:0019627) | 4.02025588 |
| 41 | urea cycle (GO:0000050) | 4.02025588 |
| 42 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.01374582 |
| 43 | glyoxylate metabolic process (GO:0046487) | 4.01146160 |
| 44 | indole-containing compound catabolic process (GO:0042436) | 4.00521847 |
| 45 | indolalkylamine catabolic process (GO:0046218) | 4.00521847 |
| 46 | tryptophan catabolic process (GO:0006569) | 4.00521847 |
| 47 | lipoxygenase pathway (GO:0019372) | 4.00042599 |
| 48 | phospholipid efflux (GO:0033700) | 3.93824356 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 3.91340928 |
| 50 | complement activation, alternative pathway (GO:0006957) | 3.91230069 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.91122285 |
| 52 | aldehyde catabolic process (GO:0046185) | 3.90477587 |
| 53 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.90096951 |
| 54 | regulation of cholesterol esterification (GO:0010872) | 3.89817913 |
| 55 | positive regulation of protein autophosphorylation (GO:0031954) | 3.87231218 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 3.86879836 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 3.86879836 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.86879836 |
| 59 | negative regulation of heart rate (GO:0010459) | 3.86496019 |
| 60 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.82864128 |
| 61 | tryptophan metabolic process (GO:0006568) | 3.82665072 |
| 62 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.79228312 |
| 63 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.78922839 |
| 64 | fibrinolysis (GO:0042730) | 3.78803161 |
| 65 | telomere maintenance via telomerase (GO:0007004) | 3.78601949 |
| 66 | kynurenine metabolic process (GO:0070189) | 3.77247993 |
| 67 | regulation of protein activation cascade (GO:2000257) | 3.73919612 |
| 68 | positive regulation of macrophage differentiation (GO:0045651) | 3.72338829 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 3.67015671 |
| 70 | blood coagulation, intrinsic pathway (GO:0007597) | 3.65721134 |
| 71 | cysteine metabolic process (GO:0006534) | 3.64445877 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 3.63776084 |
| 73 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.63351621 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.62742394 |
| 75 | regulation of integrin activation (GO:0033623) | 3.61686201 |
| 76 | platelet degranulation (GO:0002576) | 3.59962551 |
| 77 | regulation of mast cell activation (GO:0033003) | 3.59851266 |
| 78 | megakaryocyte development (GO:0035855) | 3.59087053 |
| 79 | alpha-linolenic acid metabolic process (GO:0036109) | 3.57846443 |
| 80 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.55980156 |
| 81 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.54310479 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 3.50996997 |
| 83 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.48802571 |
| 84 | regulation of complement activation (GO:0030449) | 3.44908082 |
| 85 | cholesterol efflux (GO:0033344) | 3.42963996 |
| 86 | positive regulation of hemostasis (GO:1900048) | 3.42489216 |
| 87 | positive regulation of blood coagulation (GO:0030194) | 3.42489216 |
| 88 | leukocyte degranulation (GO:0043299) | 3.42401639 |
| 89 | cofactor catabolic process (GO:0051187) | 3.42097461 |
| 90 | arginine metabolic process (GO:0006525) | 3.41207397 |
| 91 | bile acid metabolic process (GO:0008206) | 3.40609187 |
| 92 | acute-phase response (GO:0006953) | 3.40445052 |
| 93 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.35608100 |
| 94 | positive regulation of mast cell degranulation (GO:0043306) | 3.35608100 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.35602508 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.35106948 |
| 97 | homotypic cell-cell adhesion (GO:0034109) | 3.34469592 |
| 98 | platelet activation (GO:0030168) | 3.34202367 |
| 99 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.31512698 |
| 100 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.30316849 |
| 101 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.30300492 |
| 102 | positive regulation of receptor recycling (GO:0001921) | 3.29842537 |
| 103 | regulation of mast cell degranulation (GO:0043304) | 3.29369094 |
| 104 | acylglycerol homeostasis (GO:0055090) | 3.29274108 |
| 105 | triglyceride homeostasis (GO:0070328) | 3.29274108 |
| 106 | purinergic receptor signaling pathway (GO:0035587) | 3.28783448 |
| 107 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.28287663 |
| 108 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.28287663 |
| 109 | positive regulation of coagulation (GO:0050820) | 3.24426272 |
| 110 | regulation of lipoprotein metabolic process (GO:0050746) | 3.23018205 |
| 111 | homocysteine metabolic process (GO:0050667) | 3.22499798 |
| 112 | amino-acid betaine metabolic process (GO:0006577) | 3.21881416 |
| 113 | respiratory burst (GO:0045730) | 3.20944745 |
| 114 | negative regulation of hemostasis (GO:1900047) | 3.19591853 |
| 115 | negative regulation of blood coagulation (GO:0030195) | 3.19591853 |
| 116 | tyrosine metabolic process (GO:0006570) | 3.18197500 |
| 117 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.17451477 |
| 118 | cholesterol homeostasis (GO:0042632) | 3.17137262 |
| 119 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.17136573 |
| 120 | sulfur amino acid catabolic process (GO:0000098) | 3.15004607 |
| 121 | sterol homeostasis (GO:0055092) | 3.12663083 |
| 122 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.11814115 |
| 123 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.11674906 |
| 124 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.11479361 |
| 125 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.11225316 |
| 126 | negative regulation of sterol transport (GO:0032372) | 3.11022070 |
| 127 | negative regulation of cholesterol transport (GO:0032375) | 3.11022070 |
| 128 | negative regulation of coagulation (GO:0050819) | 3.10192097 |
| 129 | protein activation cascade (GO:0072376) | 3.09398647 |
| 130 | regulation of memory T cell differentiation (GO:0043380) | 3.09368003 |
| 131 | phospholipid homeostasis (GO:0055091) | 3.08564402 |
| 132 | protein-lipid complex assembly (GO:0065005) | 3.08499571 |
| 133 | aromatic amino acid family metabolic process (GO:0009072) | 3.07463113 |
| 134 | negative regulation of protein localization to cell surface (GO:2000009) | 3.07158444 |
| 135 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.07079958 |
| 136 | neutrophil activation involved in immune response (GO:0002283) | 3.06580172 |
| 137 | RNA-dependent DNA replication (GO:0006278) | 3.05979796 |
| 138 | cellular response to cadmium ion (GO:0071276) | 3.05578045 |
| 139 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.05485646 |
| 140 | myeloid cell activation involved in immune response (GO:0002275) | 3.05021166 |
| 141 | beta-amyloid metabolic process (GO:0050435) | 3.04919490 |
| 142 | negative regulation of response to food (GO:0032096) | 3.04855276 |
| 143 | negative regulation of appetite (GO:0032099) | 3.04855276 |
| 144 | protein-lipid complex subunit organization (GO:0071825) | 3.04853078 |
| 145 | microglial cell activation (GO:0001774) | 3.02971858 |
| 146 | cholesterol transport (GO:0030301) | 3.02871985 |
| 147 | sterol transport (GO:0015918) | 3.02871985 |
| 148 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01491907 |
| 149 | phagocytosis, recognition (GO:0006910) | 3.00852310 |
| 150 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.00597084 |
| 151 | platelet dense granule organization (GO:0060155) | 3.00521617 |
| 152 | response to folic acid (GO:0051593) | 3.00129865 |
| 153 | peptide catabolic process (GO:0043171) | 2.98606315 |
| 154 | negative regulation of T cell apoptotic process (GO:0070233) | 2.98413030 |
| 155 | superoxide anion generation (GO:0042554) | 2.97451910 |
| 156 | plasma lipoprotein particle organization (GO:0071827) | 2.97286439 |
| 157 | NAD biosynthetic process (GO:0009435) | 2.96196402 |
| 158 | plasma lipoprotein particle assembly (GO:0034377) | 2.95240850 |
| 159 | response to nitrosative stress (GO:0051409) | 2.94690472 |
| 160 | regulation of cholesterol storage (GO:0010885) | 2.94646911 |
| 161 | regulation of hemostasis (GO:1900046) | 2.93734106 |
| 162 | regulation of blood coagulation (GO:0030193) | 2.93734106 |
| 163 | autophagic vacuole fusion (GO:0000046) | 2.93326159 |
| 164 | positive regulation of granulocyte differentiation (GO:0030854) | 2.93011776 |
| 165 | opsonization (GO:0008228) | 2.92445345 |
| 166 | endothelium development (GO:0003158) | 2.92421429 |
| 167 | regulation of regulatory T cell differentiation (GO:0045589) | 2.92048658 |
| 168 | regulation of appetite (GO:0032098) | 2.92042387 |
| 169 | negative regulation of heart contraction (GO:0045822) | 2.90415821 |
| 170 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.85021704 |
| 171 | negative regulation of interleukin-17 production (GO:0032700) | 2.84830103 |
| 172 | polyamine biosynthetic process (GO:0006596) | 2.82978809 |
| 173 | phagocytosis, engulfment (GO:0006911) | 2.81114679 |
| 174 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.78322796 |
| 175 | mucosal immune response (GO:0002385) | 2.77216948 |
| 176 | regulation of cholesterol efflux (GO:0010874) | 2.75543818 |
| 177 | termination of signal transduction (GO:0023021) | 2.74055312 |
| 178 | extracellular fibril organization (GO:0043206) | 2.73326444 |
| 179 | positive regulation of B cell mediated immunity (GO:0002714) | 2.72270595 |
| 180 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.72270595 |
| 181 | activated T cell proliferation (GO:0050798) | 2.71377278 |
| 182 | regulation of norepinephrine secretion (GO:0014061) | 2.69799315 |
| 183 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.69682263 |
| 184 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.68783849 |
| 185 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.68300228 |
| 186 | cellular extravasation (GO:0045123) | 2.67925589 |
| 187 | regulation of coagulation (GO:0050818) | 2.64651728 |
| 188 | organ or tissue specific immune response (GO:0002251) | 2.64452668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.59852989 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63378455 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.95936879 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.44272645 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.42077915 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.69526437 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.49768683 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.43252169 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.41711142 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.19472399 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.01661652 |
| 12 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.91832507 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.87255257 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.59717205 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.58778681 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.45766114 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.43363710 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.40823879 |
| 19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36110756 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35093771 |
| 21 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28392913 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.26097279 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.06293146 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.05975434 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.01776635 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01361919 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94190081 |
| 28 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.90744660 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.83188486 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.79187762 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77027641 |
| 32 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.72008111 |
| 33 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.71671068 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71341650 |
| 35 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.71277588 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68960268 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68956143 |
| 38 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68700308 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.67267315 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66049468 |
| 41 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.60744779 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54985335 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53821886 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48456907 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43646152 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43317189 |
| 47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.42658079 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.41719513 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41579323 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40806278 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40806278 |
| 52 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.40262095 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37282019 |
| 54 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.30775018 |
| 55 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.27648218 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24246431 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21780743 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21323754 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20441457 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20213122 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19800837 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18759080 |
| 63 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18094700 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.17176543 |
| 65 | MYB_26560356_Chip-Seq_TH2_Human | 1.16739695 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14439349 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14286829 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13761746 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12493731 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12068299 |
| 71 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11669414 |
| 72 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.10533320 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09811342 |
| 74 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08436199 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06775198 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03958020 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03421910 |
| 78 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.02892051 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02327496 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01993237 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01660986 |
| 82 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01419023 |
| 83 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01196594 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00737187 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00286949 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00100599 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99791415 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99342511 |
| 89 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98963561 |
| 90 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98565147 |
| 91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98534602 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98335164 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96712540 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95860051 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95270379 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.94317728 |
| 97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94273011 |
| 98 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93707414 |
| 99 | MYB_26560356_Chip-Seq_TH1_Human | 0.93088026 |
| 100 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92286553 |
| 101 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89331454 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88074377 |
| 103 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87461068 |
| 104 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87435161 |
| 105 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87182000 |
| 106 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.86983262 |
| 107 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85617324 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85369231 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85208301 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83305980 |
| 111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82283786 |
| 112 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81441780 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81030530 |
| 114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80502698 |
| 115 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80385573 |
| 116 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80340921 |
| 117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80289077 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80001607 |
| 119 | VDR_22108803_ChIP-Seq_LS180_Human | 0.79589058 |
| 120 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.79538282 |
| 121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78757346 |
| 122 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78502496 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77767469 |
| 124 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.77723487 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77648386 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77421919 |
| 127 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.76987225 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76245580 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76029109 |
| 130 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75725864 |
| 131 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.75293034 |
| 132 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74939755 |
| 133 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74771892 |
| 134 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.74375864 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74092983 |
| 136 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73732519 |
| 137 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71415836 |
| 138 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.70156628 |
| 139 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70142899 |
| 140 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.69943416 |
| 141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69158154 |
| 142 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.69107772 |
| 143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69100170 |
| 144 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68281332 |
| 145 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.67623240 |
| 146 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.66977422 |
| 147 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.66265956 |
| 148 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65482929 |
| 149 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.64962585 |
| 150 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62796944 |
| 151 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.61489105 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61485473 |
| 153 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60751035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.91676193 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 5.15949655 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.69004296 |
| 4 | MP0008004_abnormal_stomach_pH | 4.48620914 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.68969943 |
| 6 | MP0000465_gastrointestinal_hemorrhage | 3.10110870 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.05830126 |
| 8 | MP0005365_abnormal_bile_salt | 3.05791208 |
| 9 | MP0010368_abnormal_lymphatic_system | 2.70920199 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.69337438 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.57071346 |
| 12 | MP0004510_myositis | 2.36316952 |
| 13 | MP0009840_abnormal_foam_cell | 2.32870876 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.30458376 |
| 15 | MP0003724_increased_susceptibility_to | 2.28826334 |
| 16 | MP0005167_abnormal_blood-brain_barrier | 2.27842922 |
| 17 | MP0003950_abnormal_plasma_membrane | 2.23723511 |
| 18 | MP0003252_abnormal_bile_duct | 2.22686990 |
| 19 | MP0001853_heart_inflammation | 2.20858089 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.96915384 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.95417279 |
| 22 | MP0009785_altered_susceptibility_to | 1.95207993 |
| 23 | MP0002332_abnormal_exercise_endurance | 1.93891274 |
| 24 | * MP0001879_abnormal_lymphatic_vessel | 1.92608742 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.89603350 |
| 26 | MP0003436_decreased_susceptibility_to | 1.81065460 |
| 27 | MP0001851_eye_inflammation | 1.76001301 |
| 28 | MP0009764_decreased_sensitivity_to | 1.75584571 |
| 29 | MP0003638_abnormal_response/metabolism_ | 1.74419163 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.74110579 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.71352252 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.69648553 |
| 33 | MP0003828_pulmonary_edema | 1.69335789 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.67027239 |
| 35 | MP0002736_abnormal_nociception_after | 1.63467379 |
| 36 | MP0003075_altered_response_to | 1.62632395 |
| 37 | MP0004084_abnormal_cardiac_muscle | 1.61691927 |
| 38 | * MP0002398_abnormal_bone_marrow | 1.59791144 |
| 39 | MP0004130_abnormal_muscle_cell | 1.59506796 |
| 40 | MP0002132_abnormal_respiratory_system | 1.57677002 |
| 41 | MP0002419_abnormal_innate_immunity | 1.57094961 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.55674285 |
| 43 | * MP0000230_abnormal_systemic_arterial | 1.55500551 |
| 44 | MP0005083_abnormal_biliary_tract | 1.48894788 |
| 45 | MP0004782_abnormal_surfactant_physiolog | 1.44576815 |
| 46 | MP0004883_abnormal_blood_vessel | 1.43638135 |
| 47 | * MP0005464_abnormal_platelet_physiology | 1.41435328 |
| 48 | MP0005410_abnormal_fertilization | 1.41163888 |
| 49 | MP0005332_abnormal_amino_acid | 1.40417417 |
| 50 | MP0003718_maternal_effect | 1.39119605 |
| 51 | MP0004947_skin_inflammation | 1.37070076 |
| 52 | MP0005025_abnormal_response_to | 1.35826291 |
| 53 | MP0009697_abnormal_copulation | 1.35557434 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.34216821 |
| 55 | MP0003195_calcinosis | 1.33297003 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.30764220 |
| 57 | MP0000609_abnormal_liver_physiology | 1.30740793 |
| 58 | MP0008872_abnormal_physiological_respon | 1.29579413 |
| 59 | MP0001764_abnormal_homeostasis | 1.25839287 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.24378358 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.23913711 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.21768346 |
| 63 | MP0000858_altered_metastatic_potential | 1.20685490 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 1.20245494 |
| 65 | * MP0002429_abnormal_blood_cell | 1.19839532 |
| 66 | MP0005164_abnormal_response_to | 1.18415996 |
| 67 | MP0004036_abnormal_muscle_relaxation | 1.18339264 |
| 68 | MP0008775_abnormal_heart_ventricle | 1.18326639 |
| 69 | MP0008469_abnormal_protein_level | 1.18189726 |
| 70 | MP0002722_abnormal_immune_system | 1.15170098 |
| 71 | * MP0000716_abnormal_immune_system | 1.15034993 |
| 72 | MP0008874_decreased_physiological_sensi | 1.13519004 |
| 73 | MP0003866_abnormal_defecation | 1.12772569 |
| 74 | MP0005310_abnormal_salivary_gland | 1.12414839 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 1.12344265 |
| 76 | MP0003879_abnormal_hair_cell | 1.11411060 |
| 77 | MP0001666_abnormal_nutrient_absorption | 1.08007450 |
| 78 | MP0003045_fibrosis | 1.06622933 |
| 79 | MP0005165_increased_susceptibility_to | 1.06018908 |
| 80 | MP0003303_peritoneal_inflammation | 1.04901857 |
| 81 | MP0003300_gastrointestinal_ulcer | 1.04295017 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.04036971 |
| 83 | MP0006082_CNS_inflammation | 1.01065601 |
| 84 | MP0009379_abnormal_foot_pigmentation | 1.00649170 |
| 85 | MP0001845_abnormal_inflammatory_respons | 0.99776452 |
| 86 | MP0009763_increased_sensitivity_to | 0.99313033 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98696951 |
| 88 | MP0001968_abnormal_touch/_nociception | 0.98647068 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.98153947 |
| 90 | MP0004272_abnormal_basement_membrane | 0.97840661 |
| 91 | MP0003186_abnormal_redox_activity | 0.97819041 |
| 92 | MP0005000_abnormal_immune_tolerance | 0.97276420 |
| 93 | MP0002452_abnormal_antigen_presenting | 0.95767999 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.95505197 |
| 95 | * MP0000249_abnormal_blood_vessel | 0.95222214 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.94416052 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.93880926 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 0.93853913 |
| 99 | * MP0009642_abnormal_blood_homeostasis | 0.93697940 |
| 100 | MP0003690_abnormal_glial_cell | 0.92787418 |
| 101 | MP0005395_other_phenotype | 0.92761019 |
| 102 | MP0009643_abnormal_urine_homeostasis | 0.88148495 |
| 103 | MP0002723_abnormal_immune_serum | 0.88139656 |
| 104 | MP0005671_abnormal_response_to | 0.86164231 |
| 105 | MP0005387_immune_system_phenotype | 0.85693934 |
| 106 | MP0001790_abnormal_immune_system | 0.85693934 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.85080791 |
| 108 | MP0006054_spinal_hemorrhage | 0.84843261 |
| 109 | MP0003763_abnormal_thymus_physiology | 0.84198893 |
| 110 | MP0003011_delayed_dark_adaptation | 0.82911627 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.82361453 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.82328304 |
| 113 | MP0004484_altered_response_of | 0.81726832 |
| 114 | MP0009278_abnormal_bone_marrow | 0.81117490 |
| 115 | MP0008260_abnormal_autophagy | 0.80936659 |
| 116 | MP0000598_abnormal_liver_morphology | 0.80580360 |
| 117 | MP0004147_increased_porphyrin_level | 0.80149513 |
| 118 | MP0004381_abnormal_hair_follicle | 0.79667502 |
| 119 | MP0005647_abnormal_sex_gland | 0.79387822 |
| 120 | MP0005451_abnormal_body_composition | 0.79073303 |
| 121 | MP0005646_abnormal_pituitary_gland | 0.76639125 |
| 122 | MP0005595_abnormal_vascular_smooth | 0.76584208 |
| 123 | MP0005376_homeostasis/metabolism_phenot | 0.76363765 |
| 124 | MP0000343_altered_response_to | 0.75696923 |
| 125 | MP0001800_abnormal_humoral_immune | 0.75210083 |
| 126 | MP0000703_abnormal_thymus_morphology | 0.74981082 |
| 127 | MP0002405_respiratory_system_inflammati | 0.74278612 |
| 128 | MP0001819_abnormal_immune_cell | 0.74201843 |
| 129 | * MP0010155_abnormal_intestine_physiology | 0.73586692 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.73314393 |
| 131 | MP0000685_abnormal_immune_system | 0.73071751 |
| 132 | MP0002420_abnormal_adaptive_immunity | 0.72237491 |
| 133 | MP0001881_abnormal_mammary_gland | 0.71766327 |
| 134 | MP0001970_abnormal_pain_threshold | 0.71282966 |
| 135 | MP0005166_decreased_susceptibility_to | 0.70034422 |
| 136 | MP0006276_abnormal_autonomic_nervous | 0.69519253 |
| 137 | MP0005266_abnormal_metabolism | 0.68151637 |
| 138 | MP0004215_abnormal_myocardial_fiber | 0.68039598 |
| 139 | MP0002971_abnormal_brown_adipose | 0.67674528 |
| 140 | MP0002876_abnormal_thyroid_physiology | 0.67515136 |
| 141 | MP0005670_abnormal_white_adipose | 0.66925207 |
| 142 | MP0003136_yellow_coat_color | 0.66391021 |
| 143 | MP0001545_abnormal_hematopoietic_system | 0.65394968 |
| 144 | MP0005397_hematopoietic_system_phenotyp | 0.65394968 |
| 145 | MP0001663_abnormal_digestive_system | 0.64042673 |
| 146 | MP0003868_abnormal_feces_composition | 0.64027534 |
| 147 | MP0005535_abnormal_body_temperature | 0.63468988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.42822441 |
| 2 | Petechiae (HP:0000967) | 8.90636943 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.72505298 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.80863559 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.43900599 |
| 6 | Joint hemorrhage (HP:0005261) | 5.15811493 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.97708059 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.88007699 |
| 9 | Frequent falls (HP:0002359) | 4.58092376 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 4.52661707 |
| 11 | Hypercholesterolemia (HP:0003124) | 4.44877003 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.42465890 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.24066055 |
| 14 | Recurrent abscess formation (HP:0002722) | 4.10536891 |
| 15 | Poikilocytosis (HP:0004447) | 4.03813615 |
| 16 | Xanthomatosis (HP:0000991) | 4.03372893 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.90572856 |
| 18 | Dyschromatopsia (HP:0007641) | 3.76577895 |
| 19 | Acanthocytosis (HP:0001927) | 3.68912574 |
| 20 | Complement deficiency (HP:0004431) | 3.50750834 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.49555450 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.48549584 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.40216699 |
| 24 | Bruising susceptibility (HP:0000978) | 3.35055763 |
| 25 | Stomatitis (HP:0010280) | 3.34670943 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.12773321 |
| 27 | Abnormal pupillary function (HP:0007686) | 3.12382650 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.08716809 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.04366996 |
| 30 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.03220123 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 3.00622860 |
| 32 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.96649872 |
| 33 | Menorrhagia (HP:0000132) | 2.95176503 |
| 34 | Paralysis (HP:0003470) | 2.92990932 |
| 35 | Hypolipoproteinemia (HP:0010981) | 2.88052478 |
| 36 | Recurrent skin infections (HP:0001581) | 2.86313149 |
| 37 | Gingivitis (HP:0000230) | 2.82558433 |
| 38 | Growth hormone excess (HP:0000845) | 2.81789435 |
| 39 | Arterial thrombosis (HP:0004420) | 2.80630109 |
| 40 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.80420148 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.79690223 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.77705121 |
| 43 | Gingival bleeding (HP:0000225) | 2.76911004 |
| 44 | Mucosal telangiectasiae (HP:0100579) | 2.74908504 |
| 45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.74527155 |
| 46 | Epidermoid cyst (HP:0200040) | 2.70366404 |
| 47 | Glomerulonephritis (HP:0000099) | 2.69552814 |
| 48 | Encephalitis (HP:0002383) | 2.69355147 |
| 49 | Myocardial infarction (HP:0001658) | 2.68065946 |
| 50 | Purpura (HP:0000979) | 2.67293915 |
| 51 | Tinnitus (HP:0000360) | 2.66593288 |
| 52 | Abnormality of lateral ventricle (HP:0030047) | 2.65650433 |
| 53 | Increased density of long bones (HP:0006392) | 2.64365303 |
| 54 | Obstructive lung disease (HP:0006536) | 2.64356613 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.64356613 |
| 56 | Amyloidosis (HP:0011034) | 2.63869559 |
| 57 | Abnormality of complement system (HP:0005339) | 2.62554903 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.61162947 |
| 59 | Joint swelling (HP:0001386) | 2.60783943 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.54883458 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 2.54268743 |
| 62 | Hepatosplenomegaly (HP:0001433) | 2.54216779 |
| 63 | Glucose intolerance (HP:0000833) | 2.53510666 |
| 64 | Optic neuritis (HP:0100653) | 2.52526724 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 2.52526724 |
| 66 | Fat malabsorption (HP:0002630) | 2.50594045 |
| 67 | Spontaneous abortion (HP:0005268) | 2.49402949 |
| 68 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.45130772 |
| 69 | Esophageal varix (HP:0002040) | 2.44758741 |
| 70 | Episodic fever (HP:0001954) | 2.42561584 |
| 71 | Xerostomia (HP:0000217) | 2.42017704 |
| 72 | Bone cyst (HP:0012062) | 2.40828830 |
| 73 | Pancreatitis (HP:0001733) | 2.40184055 |
| 74 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39957238 |
| 75 | Thrombophlebitis (HP:0004418) | 2.34722841 |
| 76 | Increased IgM level (HP:0003496) | 2.34358960 |
| 77 | Abnormality of methionine metabolism (HP:0010901) | 2.32257475 |
| 78 | Dysdiadochokinesis (HP:0002075) | 2.31227539 |
| 79 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.31158080 |
| 80 | Hyperammonemia (HP:0001987) | 2.31131636 |
| 81 | Recurrent fungal infections (HP:0002841) | 2.29741203 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.29538654 |
| 83 | Abnormal glucose tolerance (HP:0001952) | 2.29169108 |
| 84 | Hypertriglyceridemia (HP:0002155) | 2.28569613 |
| 85 | Hepatocellular carcinoma (HP:0001402) | 2.27020100 |
| 86 | Orchitis (HP:0100796) | 2.26625508 |
| 87 | Urticaria (HP:0001025) | 2.25989286 |
| 88 | Cellulitis (HP:0100658) | 2.25939624 |
| 89 | Epistaxis (HP:0000421) | 2.25432086 |
| 90 | Pulmonary embolism (HP:0002204) | 2.25163047 |
| 91 | Decreased central vision (HP:0007663) | 2.20946678 |
| 92 | Vertigo (HP:0002321) | 2.18819015 |
| 93 | Beaking of vertebral bodies (HP:0004568) | 2.18540224 |
| 94 | Myositis (HP:0100614) | 2.17459503 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.16197431 |
| 96 | Conjunctival telangiectasia (HP:0000524) | 2.15417119 |
| 97 | Hyperbilirubinemia (HP:0002904) | 2.13776982 |
| 98 | Hypoglycemic coma (HP:0001325) | 2.10946631 |
| 99 | Delayed CNS myelination (HP:0002188) | 2.10927941 |
| 100 | Pulmonary infiltrates (HP:0002113) | 2.10259512 |
| 101 | Abnormality of saccadic eye movements (HP:0000570) | 2.10092745 |
| 102 | Basal ganglia calcification (HP:0002135) | 2.08756295 |
| 103 | Abnormal auditory evoked potentials (HP:0006958) | 2.08578058 |
| 104 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07870208 |
| 105 | Hyperglycinuria (HP:0003108) | 2.05679100 |
| 106 | Gaze-evoked nystagmus (HP:0000640) | 2.05503351 |
| 107 | Ventricular fibrillation (HP:0001663) | 2.05204467 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.04936459 |
| 109 | Impaired platelet aggregation (HP:0003540) | 2.04084488 |
| 110 | Abnormal platelet function (HP:0011869) | 2.04084488 |
| 111 | Autoimmune thrombocytopenia (HP:0001973) | 2.03854218 |
| 112 | Polycythemia (HP:0001901) | 2.02733257 |
| 113 | Microcytic anemia (HP:0001935) | 2.02004102 |
| 114 | Lower limb hyperreflexia (HP:0002395) | 2.01462324 |
| 115 | Increased serum ferritin (HP:0003281) | 2.01277062 |
| 116 | Abnormality of the lumbar spine (HP:0100712) | 2.00261363 |
| 117 | Abnormality of Sharpey fibers (HP:0100685) | 1.99477345 |
| 118 | Chest pain (HP:0100749) | 1.98288150 |
| 119 | Osteomyelitis (HP:0002754) | 1.96135163 |
| 120 | Conjugated hyperbilirubinemia (HP:0002908) | 1.95242954 |
| 121 | Abnormal platelet volume (HP:0011876) | 1.95106459 |
| 122 | Keratoconjunctivitis (HP:0001096) | 1.94616505 |
| 123 | Male infertility (HP:0003251) | 1.94556237 |
| 124 | Abnormality of nucleobase metabolism (HP:0010932) | 1.93610734 |
| 125 | Nephritis (HP:0000123) | 1.93183842 |
| 126 | Hyperglycinemia (HP:0002154) | 1.91461753 |
| 127 | Ketosis (HP:0001946) | 1.90376901 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.90129168 |
| 129 | Prolonged bleeding time (HP:0003010) | 1.90070654 |
| 130 | Cerebral hemorrhage (HP:0001342) | 1.89799803 |
| 131 | Cholelithiasis (HP:0001081) | 1.89520182 |
| 132 | Steatorrhea (HP:0002570) | 1.88005547 |
| 133 | Thyroid-stimulating hormone excess (HP:0002925) | 1.87679281 |
| 134 | Generalized aminoaciduria (HP:0002909) | 1.87570677 |
| 135 | Abnormality of the prostate (HP:0008775) | 1.87555912 |
| 136 | Keratoconjunctivitis sicca (HP:0001097) | 1.85661523 |
| 137 | Upper limb muscle weakness (HP:0003484) | 1.83326710 |
| 138 | Arthropathy (HP:0003040) | 1.83064688 |
| 139 | Papillary thyroid carcinoma (HP:0002895) | 1.81357583 |
| 140 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80048208 |
| 141 | Nausea (HP:0002018) | 1.78310528 |
| 142 | Dysostosis multiplex (HP:0000943) | 1.73312621 |
| 143 | Muscle fibrillation (HP:0010546) | 1.70336538 |
| 144 | Autoimmune hemolytic anemia (HP:0001890) | 1.69952934 |
| 145 | Leukocytosis (HP:0001974) | 1.68226920 |
| 146 | Vasculitis (HP:0002633) | 1.66742491 |
| 147 | Dysautonomia (HP:0002459) | 1.64313312 |
| 148 | Gangrene (HP:0100758) | 1.64240133 |
| 149 | Meningitis (HP:0001287) | 1.62910705 |
| 150 | Tongue fasciculations (HP:0001308) | 1.60709222 |
| 151 | Testicular neoplasm (HP:0010788) | 1.60421061 |
| 152 | Cerebral ischemia (HP:0002637) | 1.59074311 |
| 153 | 3-Methylglutaconic aciduria (HP:0003535) | 1.58843461 |
| 154 | Thrombocytosis (HP:0001894) | 1.57596085 |
| 155 | Anorexia (HP:0002039) | 1.56553300 |
| 156 | Abnormal ciliary motility (HP:0012262) | 1.55234629 |
| 157 | Glomerulopathy (HP:0100820) | 1.52411800 |
| 158 | Eosinophilia (HP:0001880) | 1.50159706 |
| 159 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.50120042 |
| 160 | Hypophosphatemic rickets (HP:0004912) | 1.48933772 |
| 161 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.47967117 |
| 162 | Diplopia (HP:0000651) | 1.47367246 |
| 163 | Abnormality of binocular vision (HP:0011514) | 1.47367246 |
| 164 | Arthralgia (HP:0002829) | 1.47286273 |
| 165 | Biliary tract neoplasm (HP:0100574) | 1.46957923 |
| 166 | Granulocytopenia (HP:0001913) | 1.46592238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.45138597 |
| 2 | BLK | 3.91722431 |
| 3 | BMPR1B | 3.77703934 |
| 4 | KDR | 3.58236970 |
| 5 | BMX | 3.48649626 |
| 6 | RIPK4 | 3.13815471 |
| 7 | MAP3K14 | 3.10845520 |
| 8 | ERN1 | 2.99791391 |
| 9 | TGFBR1 | 2.92965488 |
| 10 | CSF1R | 2.38102405 |
| 11 | ABL2 | 2.31236119 |
| 12 | TGFBR2 | 2.30428685 |
| 13 | IKBKE | 2.28928710 |
| 14 | GRK6 | 2.09751613 |
| 15 | TBK1 | 2.08543240 |
| 16 | CAMKK1 | 2.05878629 |
| 17 | FGR | 2.05193412 |
| 18 | PBK | 1.99982610 |
| 19 | EIF2AK1 | 1.99197106 |
| 20 | GRK5 | 1.88220324 |
| 21 | FGFR4 | 1.85944427 |
| 22 | EPHB1 | 1.84423685 |
| 23 | TYK2 | 1.84127047 |
| 24 | FRK | 1.83128779 |
| 25 | INSRR | 1.71693732 |
| 26 | BCKDK | 1.67398217 |
| 27 | NEK9 | 1.59775002 |
| 28 | MST1R | 1.57415983 |
| 29 | MST4 | 1.54355456 |
| 30 | ILK | 1.51608432 |
| 31 | GRK1 | 1.50333776 |
| 32 | MAP3K13 | 1.47536554 |
| 33 | MAPKAPK3 | 1.45996493 |
| 34 | IRAK1 | 1.41467114 |
| 35 | ADRBK2 | 1.37933227 |
| 36 | IKBKB | 1.37639888 |
| 37 | MAP2K3 | 1.34792747 |
| 38 | TNK2 | 1.32311448 |
| 39 | YES1 | 1.31715062 |
| 40 | STK3 | 1.25287971 |
| 41 | KIT | 1.22141743 |
| 42 | LATS1 | 1.17499261 |
| 43 | TEC | 1.17187693 |
| 44 | TXK | 1.16455939 |
| 45 | ACVR1B | 1.09919962 |
| 46 | IRAK4 | 1.09377458 |
| 47 | JAK2 | 1.07374673 |
| 48 | PLK2 | 1.06223533 |
| 49 | MAP3K12 | 1.06179160 |
| 50 | JAK1 | 1.05712927 |
| 51 | MAPK12 | 1.05673834 |
| 52 | SIK1 | 1.05290336 |
| 53 | STK24 | 1.03322397 |
| 54 | MAP4K1 | 1.01010215 |
| 55 | PTK6 | 1.00386728 |
| 56 | PAK1 | 0.97089988 |
| 57 | CSK | 0.96964693 |
| 58 | EPHA3 | 0.96416863 |
| 59 | ABL1 | 0.95112912 |
| 60 | LMTK2 | 0.87804527 |
| 61 | ADRBK1 | 0.87593303 |
| 62 | PDK1 | 0.84876271 |
| 63 | MAP3K5 | 0.84480751 |
| 64 | MAPK4 | 0.81867545 |
| 65 | LYN | 0.81013211 |
| 66 | SYK | 0.79174651 |
| 67 | GRK7 | 0.79088135 |
| 68 | ZAP70 | 0.76994760 |
| 69 | DAPK3 | 0.75600710 |
| 70 | SIK3 | 0.72722219 |
| 71 | RET | 0.72691959 |
| 72 | MYLK | 0.72157333 |
| 73 | MAP2K6 | 0.70616260 |
| 74 | MKNK2 | 0.69974465 |
| 75 | TAOK2 | 0.69355346 |
| 76 | PKN2 | 0.67179561 |
| 77 | ERBB4 | 0.66450422 |
| 78 | PTK2B | 0.66109698 |
| 79 | TNIK | 0.65487875 |
| 80 | BTK | 0.64540267 |
| 81 | PIK3CA | 0.64122084 |
| 82 | PRKG2 | 0.63725882 |
| 83 | PDPK1 | 0.63704665 |
| 84 | RIPK1 | 0.63320802 |
| 85 | EPHB2 | 0.63165381 |
| 86 | CDK19 | 0.62961307 |
| 87 | LCK | 0.62282921 |
| 88 | PRKD1 | 0.61577389 |
| 89 | FGFR3 | 0.61392050 |
| 90 | ERBB3 | 0.60234944 |
| 91 | PIM2 | 0.59116395 |
| 92 | MAP3K3 | 0.59067223 |
| 93 | MARK3 | 0.57173112 |
| 94 | DAPK2 | 0.55971268 |
| 95 | TAOK1 | 0.55903636 |
| 96 | EGFR | 0.55620682 |
| 97 | ITK | 0.54422025 |
| 98 | NUAK1 | 0.53916009 |
| 99 | BMPR2 | 0.53670821 |
| 100 | WNK3 | 0.53234281 |
| 101 | HCK | 0.52930407 |
| 102 | FYN | 0.52874411 |
| 103 | TLK1 | 0.51959542 |
| 104 | TRPM7 | 0.51912647 |
| 105 | ERBB2 | 0.50901122 |
| 106 | PNCK | 0.50872583 |
| 107 | PRKCD | 0.49682718 |
| 108 | CSNK1D | 0.48998458 |
| 109 | PIK3CG | 0.47859573 |
| 110 | FES | 0.47621635 |
| 111 | TESK2 | 0.46688953 |
| 112 | TAOK3 | 0.46332014 |
| 113 | PASK | 0.46070602 |
| 114 | MAP3K11 | 0.45896204 |
| 115 | GSK3A | 0.45461386 |
| 116 | MAP2K4 | 0.44630940 |
| 117 | PRKG1 | 0.44503514 |
| 118 | FER | 0.44163911 |
| 119 | EIF2AK2 | 0.44058732 |
| 120 | PRKCQ | 0.43868600 |
| 121 | INSR | 0.42947100 |
| 122 | STK4 | 0.42664722 |
| 123 | PDGFRB | 0.41210128 |
| 124 | IGF1R | 0.40186330 |
| 125 | MKNK1 | 0.40084758 |
| 126 | IRAK2 | 0.39789286 |
| 127 | PRKACG | 0.39667451 |
| 128 | MAP3K1 | 0.39642296 |
| 129 | PRKAA2 | 0.38483519 |
| 130 | MATK | 0.38438744 |
| 131 | MAP2K1 | 0.38033857 |
| 132 | CAMKK2 | 0.37270521 |
| 133 | SRC | 0.36977689 |
| 134 | PIM1 | 0.36854523 |
| 135 | MAPK11 | 0.36746024 |
| 136 | AKT3 | 0.36123057 |
| 137 | PKN1 | 0.35501623 |
| 138 | MAPK7 | 0.33323483 |
| 139 | CSNK2A2 | 0.33109037 |
| 140 | MAP3K6 | 0.32311474 |
| 141 | CHUK | 0.32251577 |
| 142 | CDK8 | 0.32206285 |
| 143 | JAK3 | 0.32158429 |
| 144 | MAPK13 | 0.31598384 |
| 145 | PRKCB | 0.31180972 |
| 146 | TRIM28 | 0.28704917 |
| 147 | DAPK1 | 0.28380518 |
| 148 | MINK1 | 0.25416314 |
| 149 | PRKCA | 0.24637841 |
| 150 | PAK3 | 0.24104918 |
| 151 | SGK2 | 0.23363535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.52818868 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.79033450 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.29969826 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07276172 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02858063 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98140762 |
| 7 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.88294403 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.81704124 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.81342902 |
| 10 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.81316290 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67829502 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.49272273 |
| 13 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.32298092 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07760116 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.05985440 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.91993612 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.89188040 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.88706061 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86949536 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82694205 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.80946196 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.80422216 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77607910 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65939110 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65809051 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62765952 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61592647 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59679689 |
| 29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.57753538 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.54833192 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50836852 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.50706856 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46040187 |
| 34 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.46006516 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.40728100 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35560020 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33111527 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30198945 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29839497 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.29195515 |
| 41 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.28425026 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.28342893 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26666529 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25578990 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24063532 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.21436404 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.21244070 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17352743 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16865070 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15802953 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 1.13447325 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 1.12978251 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12726158 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10507346 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 1.09121948 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.08785934 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07028866 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06564189 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04071842 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03978189 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00200007 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99777809 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98744692 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96892268 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95572188 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94771842 |
| 67 | Alcoholism_Homo sapiens_hsa05034 | 0.94039530 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.93008829 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.91289957 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90552716 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.90286358 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89039087 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86543203 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86472770 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84692518 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82168842 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.78779195 |
| 78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76700134 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75385080 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.75314818 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74992198 |
| 82 | Morphine addiction_Homo sapiens_hsa05032 | 0.71759104 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71011263 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.70994113 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70176938 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70135715 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66161546 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65980603 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65316796 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64253082 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63847350 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63825285 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63748835 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62538476 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62237800 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61457650 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61316659 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60850577 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.59814366 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59362754 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58455747 |
| 102 | Focal adhesion_Homo sapiens_hsa04510 | 0.58138016 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57780394 |
| 104 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57154725 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56937867 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56765065 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.56636957 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56340349 |
| 109 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56244202 |
| 110 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56103167 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55454424 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55252959 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.54040656 |
| 114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53811852 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52577313 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52283465 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51547842 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.51457317 |
| 119 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.51113843 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50161966 |
| 121 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49955744 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.49267452 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47886251 |
| 124 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47510776 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47283569 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46262023 |
| 127 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45894085 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45012374 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.45009471 |
| 130 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44656222 |
| 131 | Platelet activation_Homo sapiens_hsa04611 | 0.43978504 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43170520 |
| 133 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42442439 |
| 134 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41923862 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41440023 |
| 136 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40651456 |
| 137 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40508469 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40207873 |
| 139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39483691 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.38927847 |
| 141 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37147774 |
| 142 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36334473 |
| 143 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36206671 |
| 144 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35913498 |
| 145 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35637833 |
| 146 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34915118 |
| 147 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.34415683 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.34087788 |
| 149 | Lysine degradation_Homo sapiens_hsa00310 | 0.31246265 |
| 150 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31149711 |
| 151 | Salmonella infection_Homo sapiens_hsa05132 | 0.29451593 |
| 152 | Viral myocarditis_Homo sapiens_hsa05416 | 0.26758344 |
| 153 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.26580528 |
| 154 | Influenza A_Homo sapiens_hsa05164 | 0.25118247 |
| 155 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24695966 |
| 156 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.24589990 |
| 157 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.22451499 |
| 158 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.22406768 |

